Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes
Conditions:   Type 1 Diabetes;   Diabetes Mellitus, Type 1 Interventions:   Drug: Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®);   Drug: Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride) Sponsors:   Melbourne Health;   National Health and Medical Research Council, Australia;   Juvenile Diabetes Research Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials